Digestive Care Inc. is a privately held fully integrated pharmaceutical company that develops unique pharmaceutical products to improve complications and symptoms of gastrointestinal disorders. The company s platform technology specializes in drug therapies that utilize novel methods of drug delivery systems. Its product PANCRECARB is a pancreatic enzyme supplement for the treatment of Exocrine Pancreatic Insufficiency (EPI). Founded in 1990, the company holds 15 patents in the United States and overseas. The company also provides research, product development, manufacturing, packaging, distribution, marketing and sales.